β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis

The aim of this study was to evaluate the concentrations of b2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women. We also evaluated the relationships between b2 microglobulin and bone mineral density (BMD), par...

Full description

Bibliographic Details
Main Authors: Funda Taşçıoğlu, Yıldıray Tabak, Pınar Ulaşan, Cengiz Öner
Format: Article
Language:English
Published: Galenos Yayinevi 2003-06-01
Series:Türk Osteoporoz Dergisi
Subjects:
Online Access:http://www.turkosteoporozdergisi.org/article_4176/ve#9462-microglobulin-Levels-In-Patients-With-Postmenopausal-Osteoporosis
_version_ 1797922492922200064
author Funda Taşçıoğlu
Yıldıray Tabak
Pınar Ulaşan
Cengiz Öner
author_facet Funda Taşçıoğlu
Yıldıray Tabak
Pınar Ulaşan
Cengiz Öner
author_sort Funda Taşçıoğlu
collection DOAJ
description The aim of this study was to evaluate the concentrations of b2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women. We also evaluated the relationships between b2 microglobulin and bone mineral density (BMD), parathyroid hormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and 24 hr urinary calcium levels. For this aim, 31 postmenopausal women with osteoporosis and 22 healthy postmenopausal women were included in the study. DXA was used for the measurement of BMD of the lumbar spine and proximal femur. Laboratory assessments included serum Ca, P, ALP, PTH, b2 microglobulin levels and 24 hour urinary calcium. BMD at the lumbar spine (p< 0.001), femur neck (p<0.001), ward triangle (p<0.001), and trochanteric region (p<0.05) was significantly lower and serum b2 microglobulin (p<0.05), alkaline phosphotase (p<0.05), and parathyroid hormone (p<0.05) levels were found to be significantly higher in postmenopausal osteoporotic women as compared to healthy controls. However, b2 microglobulin was not associated with BMD at any of the measured regions and no association was found between serum PTH, ALP, Ca, P, and 24 hour urinary calcium values. Although high levels of b2 microglobulin in postmenopausal osteoporotic women suggest that it might reflect osteoclastic activity, the possible role of this polypeptide in the pathogenesis of increased bone resorption, needs further investigation.
first_indexed 2024-04-10T14:32:13Z
format Article
id doaj.art-ef2bf6585e374067b31cb63e88165f87
institution Directory Open Access Journal
issn 2147-2653
language English
last_indexed 2024-04-10T14:32:13Z
publishDate 2003-06-01
publisher Galenos Yayinevi
record_format Article
series Türk Osteoporoz Dergisi
spelling doaj.art-ef2bf6585e374067b31cb63e88165f872023-02-15T16:08:46ZengGalenos YayineviTürk Osteoporoz Dergisi2147-26532003-06-01924953β2 -Microglobulin Levels in Patients with Postmenopausal OsteoporosisFunda Taşçıoğlu0Yıldıray Tabak1Pınar Ulaşan2Cengiz Öner3Osmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim DalıOsmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim DalıOsmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim DalıOsmangazi Üniversitesi Tıp Fakültesi Fiziksel Tıp ve Rehabilitasyon Anabilim DalıThe aim of this study was to evaluate the concentrations of b2 microglobulin in patients with postmenopausal osteoporosis and compare the results with the ones obtained from healthy postmenopausal women. We also evaluated the relationships between b2 microglobulin and bone mineral density (BMD), parathyroid hormone (PTH), calcium (Ca), phosphorus (P), alkaline phosphatase (ALP), and 24 hr urinary calcium levels. For this aim, 31 postmenopausal women with osteoporosis and 22 healthy postmenopausal women were included in the study. DXA was used for the measurement of BMD of the lumbar spine and proximal femur. Laboratory assessments included serum Ca, P, ALP, PTH, b2 microglobulin levels and 24 hour urinary calcium. BMD at the lumbar spine (p< 0.001), femur neck (p<0.001), ward triangle (p<0.001), and trochanteric region (p<0.05) was significantly lower and serum b2 microglobulin (p<0.05), alkaline phosphotase (p<0.05), and parathyroid hormone (p<0.05) levels were found to be significantly higher in postmenopausal osteoporotic women as compared to healthy controls. However, b2 microglobulin was not associated with BMD at any of the measured regions and no association was found between serum PTH, ALP, Ca, P, and 24 hour urinary calcium values. Although high levels of b2 microglobulin in postmenopausal osteoporotic women suggest that it might reflect osteoclastic activity, the possible role of this polypeptide in the pathogenesis of increased bone resorption, needs further investigation.http://www.turkosteoporozdergisi.org/article_4176/ve#9462-microglobulin-Levels-In-Patients-With-Postmenopausal-Osteoporosisb2 microglobulinpostmenopausal osteoporosis
spellingShingle Funda Taşçıoğlu
Yıldıray Tabak
Pınar Ulaşan
Cengiz Öner
β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
Türk Osteoporoz Dergisi
b2 microglobulin
postmenopausal osteoporosis
title β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
title_full β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
title_fullStr β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
title_full_unstemmed β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
title_short β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
title_sort β2 microglobulin levels in patients with postmenopausal osteoporosis
topic b2 microglobulin
postmenopausal osteoporosis
url http://www.turkosteoporozdergisi.org/article_4176/ve#9462-microglobulin-Levels-In-Patients-With-Postmenopausal-Osteoporosis
work_keys_str_mv AT fundatascıoglu b2microglobulinlevelsinpatientswithpostmenopausalosteoporosis
AT yıldıraytabak b2microglobulinlevelsinpatientswithpostmenopausalosteoporosis
AT pınarulasan b2microglobulinlevelsinpatientswithpostmenopausalosteoporosis
AT cengizoner b2microglobulinlevelsinpatientswithpostmenopausalosteoporosis